HedgeEyeIs suppose to provide their bullish thesis on Ianthus in further detail this coming thursday. I'm using this FDA induced sell off as an opportunity to position in Ianthus this week. FDA is still on the hook to get the ball rolling on CBD. The market is currently pricing in a probable delay in the process, but make no mistake CBD regulation will be put into place at some point. I see this having no material impact on Ianthus in the near to medium term.